FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W118889791> ?p ?o ?g. }

• W118889791 endingPage "71" @default.
• W118889791 startingPage "S67" @default.
• W118889791 abstract "Cyclophosphamide (CYC) is thought to be the most effective treatment for antineutrophil cytoplasmatic antibody (ANCA)-associated idiopathic systemic vasculitis with severe organ or life threatening presentation. The key mechanism of action of CYC is suppression of the B lymphocyte activity. However, a considerable minority of patients either remains refractory to conventional therapy or experiences dose-limiting side effects.In the present study, rituximab (4 weekly doses of 375 mg/m2 and 2 more doses at 1-month interval) was intravenously administered as a rescue therapy to 7 patients (4 affected by idiopathic systemic microscopic polyangiitis, 2 by Wegener's granulomatosis, and 1 affected by Churg Strauss syndrome). The study group was made up of 3 women and 4 men, mean age 61.5 years (39-71), intolerant or refractory to more conventional therapy. Four patients had histologically confirmed paucimmune necrotizing glomerulonephritis.Significant decreases were observed in levels of serum creatinine, proteinuria, erythrocyte sedimentation rate, C-reactive protein, and ANCA titers within the first 12 months of follow-up. Arthralgia and weakness rapidly disappeared in all patients. Four out of five patients reported a decrease in the degree of paresthesia, paralleled by an improvement in the electrodiagnostic parameters. A significant improvement was observed in both Birmingham Vasculitis Activity Score and Vasculitis Damage Index. Side effects were negligible.In this sample of patients with idiopathic systemic vasculitis that was refractory or intolerant to conventional treatment, rituximab was found to be a safe and effective rescue therapy." @default.
• W118889791 created "2016-06-24" @default.
• W118889791 creator A5012705049 @default.
• W118889791 creator A5018929604 @default.
• W118889791 creator A5021696017 @default.
• W118889791 creator A5043758235 @default.
• W118889791 creator A5052838173 @default.
• W118889791 creator A5052966336 @default.
• W118889791 creator A5070375893 @default.
• W118889791 creator A5085155126 @default.
• W118889791 date "2008-10-24" @default.
• W118889791 modified "2023-09-23" @default.
• W118889791 title "Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement." @default.
• W118889791 cites W1964913193 @default.
• W118889791 cites W1977891218 @default.
• W118889791 cites W1981535363 @default.
• W118889791 cites W1990393482 @default.
• W118889791 cites W2023473273 @default.
• W118889791 cites W2057194530 @default.
• W118889791 cites W2071333258 @default.
• W118889791 cites W2120706571 @default.
• W118889791 cites W2126960177 @default.
• W118889791 cites W2137553845 @default.
• W118889791 cites W2157081456 @default.
• W118889791 cites W2260844430 @default.
• W118889791 cites W2264075806 @default.
• W118889791 cites W2473041787 @default.
• W118889791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18799057" @default.
• W118889791 hasPublicationYear "2008" @default.
• W118889791 type Work @default.
• W118889791 sameAs 118889791 @default.
• W118889791 citedByCount "23" @default.
• W118889791 countsByYear W1188897912013 @default.
• W118889791 countsByYear W1188897912014 @default.
• W118889791 countsByYear W1188897912015 @default.
• W118889791 countsByYear W1188897912017 @default.
• W118889791 countsByYear W1188897912018 @default.
• W118889791 countsByYear W1188897912021 @default.
• W118889791 countsByYear W1188897912023 @default.
• W118889791 crossrefType "journal-article" @default.
• W118889791 hasAuthorship W118889791A5012705049 @default.
• W118889791 hasAuthorship W118889791A5018929604 @default.
• W118889791 hasAuthorship W118889791A5021696017 @default.
• W118889791 hasAuthorship W118889791A5043758235 @default.
• W118889791 hasAuthorship W118889791A5052838173 @default.
• W118889791 hasAuthorship W118889791A5052966336 @default.
• W118889791 hasAuthorship W118889791A5070375893 @default.
• W118889791 hasAuthorship W118889791A5085155126 @default.
• W118889791 hasConcept C121332964 @default.
• W118889791 hasConcept C126322002 @default.
• W118889791 hasConcept C142424586 @default.
• W118889791 hasConcept C198451711 @default.
• W118889791 hasConcept C24040308 @default.
• W118889791 hasConcept C2775998817 @default.
• W118889791 hasConcept C2776015282 @default.
• W118889791 hasConcept C2776694085 @default.
• W118889791 hasConcept C2776755627 @default.
• W118889791 hasConcept C2777374719 @default.
• W118889791 hasConcept C2778143017 @default.
• W118889791 hasConcept C2778910314 @default.
• W118889791 hasConcept C2779134260 @default.
• W118889791 hasConcept C2779338263 @default.
• W118889791 hasConcept C2779561371 @default.
• W118889791 hasConcept C2780091579 @default.
• W118889791 hasConcept C2780306776 @default.
• W118889791 hasConcept C2780653079 @default.
• W118889791 hasConcept C71924100 @default.
• W118889791 hasConcept C87355193 @default.
• W118889791 hasConcept C90924648 @default.
• W118889791 hasConceptScore W118889791C121332964 @default.
• W118889791 hasConceptScore W118889791C126322002 @default.
• W118889791 hasConceptScore W118889791C142424586 @default.
• W118889791 hasConceptScore W118889791C198451711 @default.
• W118889791 hasConceptScore W118889791C24040308 @default.
• W118889791 hasConceptScore W118889791C2775998817 @default.
• W118889791 hasConceptScore W118889791C2776015282 @default.
• W118889791 hasConceptScore W118889791C2776694085 @default.
• W118889791 hasConceptScore W118889791C2776755627 @default.
• W118889791 hasConceptScore W118889791C2777374719 @default.
• W118889791 hasConceptScore W118889791C2778143017 @default.
• W118889791 hasConceptScore W118889791C2778910314 @default.
• W118889791 hasConceptScore W118889791C2779134260 @default.
• W118889791 hasConceptScore W118889791C2779338263 @default.
• W118889791 hasConceptScore W118889791C2779561371 @default.
• W118889791 hasConceptScore W118889791C2780091579 @default.
• W118889791 hasConceptScore W118889791C2780306776 @default.
• W118889791 hasConceptScore W118889791C2780653079 @default.
• W118889791 hasConceptScore W118889791C71924100 @default.
• W118889791 hasConceptScore W118889791C87355193 @default.
• W118889791 hasConceptScore W118889791C90924648 @default.
• W118889791 hasIssue "3 Suppl 49" @default.
• W118889791 hasLocation W1188897911 @default.
• W118889791 hasOpenAccess W118889791 @default.
• W118889791 hasPrimaryLocation W1188897911 @default.
• W118889791 hasRelatedWork W1897193160 @default.
• W118889791 hasRelatedWork W1981535363 @default.
• W118889791 hasRelatedWork W1990393482 @default.
• W118889791 hasRelatedWork W1992270926 @default.

• next